Real Estate - Services
Compare Stocks
2 / 10Stock Comparison
RMAX vs WELL
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
RMAX vs WELL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Real Estate - Services | REIT - Healthcare Facilities |
| Market Cap | $217M | $151.66B |
| Revenue (TTM) | $292M | $11.63B |
| Net Income (TTM) | $10M | $1.43B |
| Gross Margin | 56.6% | 39.1% |
| Operating Margin | 16.1% | 4.4% |
| Forward P/E | 8.2x | 79.7x |
| Total Debt | $23M | $21.38B |
| Cash & Equiv. | $119M | $5.03B |
RMAX vs WELL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| RE/MAX Holdings, In… (RMAX) | 100 | 38.0 | -62.0% |
| Welltower Inc. (WELL) | 100 | 427.2 | +327.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RMAX vs WELL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RMAX is the clearest fit if your priority is value.
- Lower P/E (8.2x vs 79.7x)
WELL carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.13, yield 1.3%
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 233.9% 10Y total return vs RMAX's -54.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs RMAX's -5.2% | |
| Value | Lower P/E (8.2x vs 79.7x) | |
| Quality / Margins | 12.3% margin vs RMAX's 3.4% | |
| Stability / Safety | Beta 0.13 vs RMAX's 1.39 | |
| Dividends | 1.3% yield, 2-year raise streak, vs RMAX's 0.2% | |
| Momentum (1Y) | +45.8% vs RMAX's +34.4% | |
| Efficiency (ROA) | 2.3% ROA vs RMAX's 1.7%, ROIC 0.5% vs 36.7% |
RMAX vs WELL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
RMAX vs WELL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
WELL leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 39.9x RMAX's $292M. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to RMAX's 3.4%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $292M | $11.6B |
| EBITDAEarnings before interest/tax | $73M | $2.8B |
| Net IncomeAfter-tax profit | $10M | $1.4B |
| Free Cash FlowCash after capex | $23M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +56.6% | +39.1% |
| Operating MarginEBIT ÷ Revenue | +16.1% | +4.4% |
| Net MarginNet income ÷ Revenue | +3.4% | +12.3% |
| FCF MarginFCF ÷ Revenue | +8.0% | +21.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -1.8% | +40.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -72.4% | +22.5% |
Valuation Metrics
RMAX leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
At 26.6x trailing earnings, RMAX trades at a 83% valuation discount to WELL's 155.7x P/E. On an enterprise value basis, RMAX's 1.7x EV/EBITDA is more attractive than WELL's 67.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $217M | $151.7B |
| Enterprise ValueMkt cap + debt − cash | $121M | $168.0B |
| Trailing P/EPrice ÷ TTM EPS | 26.57x | 155.73x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.23x | 79.69x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 1.66x | 67.37x |
| Price / SalesMarket cap ÷ Revenue | 0.74x | 14.22x |
| Price / BookPrice ÷ Book value/share | — | 3.40x |
| Price / FCFMarket cap ÷ FCF | 6.47x | 53.25x |
Profitability & Efficiency
RMAX leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs RMAX's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | +3.5% |
| ROA (TTM)Return on assets | +1.7% | +2.3% |
| ROICReturn on invested capital | +36.7% | +0.5% |
| ROCEReturn on capital employed | +10.8% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 |
| Debt / EquityFinancial leverage | — | 0.49x |
| Net DebtTotal debt minus cash | -$96M | $16.3B |
| Cash & Equiv.Liquid assets | $119M | $5.0B |
| Total DebtShort + long-term debt | $23M | $21.4B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.26x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $31,193 today (with dividends reinvested), compared to $3,483 for RMAX. Over the past 12 months, WELL leads with a +45.8% total return vs RMAX's +34.4%. The 3-year compound annual growth rate (CAGR) favors WELL at 43.3% vs RMAX's -16.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +43.6% | +16.2% |
| 1-Year ReturnPast 12 months | +34.4% | +45.8% |
| 3-Year ReturnCumulative with dividends | -41.4% | +194.0% |
| 5-Year ReturnCumulative with dividends | -65.2% | +211.9% |
| 10-Year ReturnCumulative with dividends | -54.9% | +233.9% |
| CAGR (3Y)Annualised 3-year return | -16.3% | +43.3% |
Risk & Volatility
WELL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
WELL is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than RMAX's 1.39 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WELL currently trades 98.6% from its 52-week high vs RMAX's 91.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.39x | 0.13x |
| 52-Week HighHighest price in past year | $11.62 | $219.59 |
| 52-Week LowLowest price in past year | $5.46 | $142.65 |
| % of 52W HighCurrent price vs 52-week peak | +91.5% | +98.6% |
| RSI (14)Momentum oscillator 0–100 | 75.1 | 57.6 |
| Avg Volume (50D)Average daily shares traded | 718K | 2.6M |
Analyst Outlook
WELL leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates RMAX as "Hold" and WELL as "Buy". Consensus price targets imply 56.8% upside for RMAX (target: $17) vs 4.6% for WELL (target: $227). For income investors, WELL offers the higher dividend yield at 1.28% vs RMAX's 0.23%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $16.67 | $226.50 |
| # AnalystsCovering analysts | 14 | 34 |
| Dividend YieldAnnual dividend ÷ price | +0.2% | +1.3% |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | $0.02 | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
WELL leads in 4 of 6 categories (Income & Cash Flow, Total Returns). RMAX leads in 2 (Valuation Metrics, Profitability & Efficiency).
RMAX vs WELL: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is RMAX or WELL a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -5. 2% for RE/MAX Holdings, Inc. (RMAX). RE/MAX Holdings, Inc. (RMAX) offers the better valuation at 26. 6x trailing P/E (8. 2x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RMAX or WELL?
On trailing P/E, RE/MAX Holdings, Inc.
(RMAX) is the cheapest at 26. 6x versus Welltower Inc. at 155. 7x. On forward P/E, RE/MAX Holdings, Inc. is actually cheaper at 8. 2x.
03Which is the better long-term investment — RMAX or WELL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +211. 9%, compared to -65. 2% for RE/MAX Holdings, Inc. (RMAX). Over 10 years, the gap is even starker: WELL returned +233. 9% versus RMAX's -54. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RMAX or WELL?
By beta (market sensitivity over 5 years), Welltower Inc.
(WELL) is the lower-risk stock at 0. 13β versus RE/MAX Holdings, Inc. 's 1. 39β — meaning RMAX is approximately 949% more volatile than WELL relative to the S&P 500.
05Which is growing faster — RMAX or WELL?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus -5. 2% for RE/MAX Holdings, Inc. (RMAX). On earnings-per-share growth, the picture is similar: RE/MAX Holdings, Inc. grew EPS 8. 1% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RMAX or WELL?
RE/MAX Holdings, Inc.
(RMAX) is the more profitable company, earning 8. 9% net margin versus 8. 8% for Welltower Inc. — meaning it keeps 8. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RMAX leads at 16. 1% versus 3. 3% for WELL. At the gross margin level — before operating expenses — RMAX leads at 56. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RMAX or WELL more undervalued right now?
On forward earnings alone, RE/MAX Holdings, Inc.
(RMAX) trades at 8. 2x forward P/E versus 79. 7x for Welltower Inc. — 71. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for RMAX: 56. 8% to $16. 67.
08Which pays a better dividend — RMAX or WELL?
All stocks in this comparison pay dividends.
Welltower Inc. (WELL) offers the highest yield at 1. 3%, versus 0. 2% for RE/MAX Holdings, Inc. (RMAX).
09Is RMAX or WELL better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc.
(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +233. 9% 10Y return). Both have compounded well over 10 years (WELL: +233. 9%, RMAX: -54. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RMAX and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: RMAX is a small-cap quality compounder stock; WELL is a mid-cap high-growth stock. WELL pays a dividend while RMAX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.